<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02764788</url>
  </required_header>
  <id_info>
    <org_study_id>2015/27</org_study_id>
    <secondary_id>2015-A01842-47</secondary_id>
    <nct_id>NCT02764788</nct_id>
  </id_info>
  <brief_title>Auriculotherapy Treatment in Fibromyalgia</brief_title>
  <acronym>Fib-Auric</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fibromyalgia (FM) is the most common cause of diffuse pain in the bones and joints, and one&#xD;
      of the most frequent causes of referral to the pain management unit. It affects mainly women;&#xD;
      they are referred by a rheumatologist, an internal medicine physician or by their family&#xD;
      physician.&#xD;
&#xD;
      FM produces various degrees of disability and pain, and has an important impact on quality of&#xD;
      life. Sleep disorders, fatigue and cognitive dysfunctions are almost always part of the&#xD;
      clinical presentation. The wide range of symptoms and signs, the unknown etiology, the lack&#xD;
      of efficacy of pharmacological treatments make management of FM a very difficult task. In&#xD;
      France the consensus includes limitation of pharmacological treatment, encouraging physical&#xD;
      rehabilitation and referring the patients to a specialized pain clinic where&#xD;
      multidisciplinary management will be undertaken. In our hospital the investigators favor non&#xD;
      pharmacological therapies and propose to the FM patients to learn relaxation and&#xD;
      self-hypnosis, physical rehabilitation and use of trans cutaneous electrical&#xD;
      neurostimulation.&#xD;
&#xD;
      Auriculotherapy (AT) is a complementary therapy, based on the idea that the ear is a&#xD;
      microsystem which reflects the entire body, represented on the auricle, the outer portion of&#xD;
      the ear. Mapping of the auricle has been described, according to the fact that pathology of&#xD;
      different organs can induce specific changes in the auricle, for example color change or&#xD;
      sensitivity. Treating specific areas, which somehow would be &quot;connected&quot; to the affected&#xD;
      organ could also improve the functioning of the body or relieve pain. AT uses placement of&#xD;
      needles at points tailored to the patient's pathology. Whatever the mechanisms involved, the&#xD;
      effectiveness of ATis currently supported by randomized controlled trials. It is validated by&#xD;
      WHO since 1987, mapped in an international nomenclature initially proposed by Nogier.&#xD;
&#xD;
      The investigators regularly use AT in FM patients in our pain management unit to alleviate&#xD;
      symptoms as pain, sleep disorders, anxiety. The investigators established a clinical trial in&#xD;
      this population to assess impact of FM (assessed with Fibromyalgia Impact Questionnaire)&#xD;
      following 3 months of AT management (Primary Outcome). Sleep disorder, fatigue, anxiety and&#xD;
      depression, cognitive and physical dysfunction are also evaluated as secondary outcomes. The&#xD;
      remnant effect of AT is also evaluated, 3 month after the end of the treatment by the same&#xD;
      tests.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 27, 2016</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of otherapy on the health of patients with fibromyalgia syndrome</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>Specific auriculotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Auriculotherapy on specific points with needles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-specific auriculotherapy</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Auriculotherapy on non-specific auriculotherapy points with needles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Seed auriculotherapy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Auriculotherapy on non-specific auriculotherapy points with seeds</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Specific auriculotherapy</intervention_name>
    <description>Specific auriculotherapy with needles</description>
    <arm_group_label>Specific auriculotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>non-specific auriculotherapy</intervention_name>
    <description>non-specific auriculotherapy with needles</description>
    <arm_group_label>Non-specific auriculotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>seed auriculotherapy</intervention_name>
    <description>non-specific auriculotherapy with seeds</description>
    <arm_group_label>Seed auriculotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  fibromyalgia (criteria from ACR)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history or existing of inflammatory rheumatims, lupus, systemic diseases that may&#xD;
             explain the pain syndrom&#xD;
&#xD;
          -  history or existing of severe psychiatric desorder&#xD;
&#xD;
          -  history or existing of hemophilia&#xD;
&#xD;
          -  with anticoagulant treatment&#xD;
&#xD;
          -  local counterindication to auriculotherapy&#xD;
&#xD;
          -  valvular prosthesis&#xD;
&#xD;
          -  auriculotherapy during the last 12 months&#xD;
&#xD;
          -  new psychotherpeutic treatment which interfer with auriculotherapy&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  breath feeding&#xD;
&#xD;
          -  RMI for the next 5 months&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mireille Michel-Cherqui, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Foch</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mireille Michel-Cherqui, MD</last_name>
    <phone>+33(0)146252985</phone>
    <email>m.michel-cherqui@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mireille Michel-Cherqui, MD</last_name>
      <phone>+33(0)146252985</phone>
      <email>m.michel-cherqui@hopital-foch.org</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 4, 2016</study_first_submitted>
  <study_first_submitted_qc>May 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2016</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Auriculotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

